TORONTO, ONTARIO--(Marketwire - February 12, 2008) - Attention: Business/Financial Editors: The Medipattern Corporation (TSX VENTURE: MKI), an award-winning developer of computer-aided detection (CAD) medical imaging software designed to aid physicians in making better informed biopsy decisions and to permit a higher standard of care for the millions of patients at risk of cancer, is pleased to announce the publication of a study showing a significant increase in diagnostic accuracy when using B-CAD v2 on lesions less than 1 cm in size (B-CAD v2 is only available outside the United States).
